Stay updated on BTD-001 in IH & Narcolepsy Type 2 Clinical Trial
Sign up to get notified when there's something new on the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page.

Latest updates to the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page
- Check4 days agoChange DetectedThe 403 error message and related page navigation are no longer shown; the page’s main content area appears blank.SummaryDifference2%

- Check11 days agoChange DetectedThe footer’s site revision label changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA sitewide NIH notice about terminology updates appears above the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study record content with a generic header and footer. This blocks access to the study details and related information on the page.SummaryDifference17%

- Check60 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an updated version of the page content.SummaryDifference0.1%

Stay in the know with updates to BTD-001 in IH & Narcolepsy Type 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page.